BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10501050)

  • 1. Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.
    Rivard MJ
    Med Phys; 1999 Aug; 26(8):1503-14. PubMed ID: 10501050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol.
    Rivard MJ; Wierzbicki JG; Van den Heuvel F; Martin RC; McMahon RR
    Med Phys; 1999 Jan; 26(1):87-96. PubMed ID: 9949403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements and calculations of thermal neutron fluence rate and neutron energy spectra resulting from moderation of 252Cf fast neutrons: applications for neutron capture therapy.
    Rivard MJ
    Med Phys; 2000 Aug; 27(8):1761-9. PubMed ID: 10984222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutron dosimetry for a general 252Cf brachytherapy source.
    Rivard MJ
    Med Phys; 2000 Dec; 27(12):2803-15. PubMed ID: 11190964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the dose components of fast and thermal neutrons and photons from a 0.1 mg 252Cf source in water for brachytherapy treatment planning.
    Wanwilairat S; Schmidt R; Vilaithong T; Lorvidhaya V; Hoffmann W
    Med Phys; 2000 Oct; 27(10):2357-62. PubMed ID: 11099203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry of 252Cf sources for neutron radiotherapy with and without augmentation by boron neutron capture therapy.
    Yanch JC; Zamenhof RG
    Radiat Res; 1992 Sep; 131(3):249-56. PubMed ID: 1438684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "Monte Carlo simulation of Cf-252 dose distribution brachytherapy" [Med. Phys. 23, 707-711 (1996)].
    Wierzbicki JG; Zamenhof R
    Med Phys; 1997 Aug; 24(8):1319; author reply 1321. PubMed ID: 9284257
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of low-pressure tissue equivalent proportional counters for the dosimetry of neutron beams used in BNCT and BNCEFNT.
    Kota C; Maughan RL; Tattam D; Beynon TD
    Med Phys; 2000 Mar; 27(3):535-48. PubMed ID: 10757605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderated 252Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose.
    Rivard MJ; Zamenhof RG
    Appl Radiat Isot; 2004 Nov; 61(5):753-7. PubMed ID: 15308139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
    Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
    Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Experimental determination of the thermal neutron flux around two different types of high intensity 252Cf source" [Med. Phys. 26, 83-86 (1999)].
    Rivard MJ
    Med Phys; 1999 Sep; 26(9):2037-8. PubMed ID: 10505897
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to "comment on 'experimental determination of the thermal neutron flux around two different types of high intensity 252Cf source'" [Med. Phys. 26, 2037-2038 (1999)].
    Schmidt R; Maughan RL; Yudelev M; Kota C; Wanwilairat S
    Med Phys; 1999 Sep; 26(9):2039-40. PubMed ID: 10505898
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of high-activity 252Cf sources for neutron brachytherapy.
    Martin RC; Laxson RR; Miller JH; Wierzbicki JG; Rivard MJ; Marsh DL
    Appl Radiat Isot; 1997; 48(10-12):1567-70. PubMed ID: 9463877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neutron sensitivity of dosimeters applied to boron neutron capture therapy.
    Raaijmakers CP; Watkins PR; Nottelman EL; Verhagen HW; Jansen JT; Zoetelief J; Mijnheer BJ
    Med Phys; 1996 Sep; 23(9):1581-9. PubMed ID: 8892256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
    Monroe JI; Dempsey JF; Dorton JA; Mutic S; Stubbs JB; Markman J; Williamson JF
    Med Phys; 2001 Jan; 28(1):73-85. PubMed ID: 11213925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).
    Tedgren AC; Hedman A; Grindborg JE; Carlsson GA
    Med Phys; 2011 Oct; 38(10):5539-50. PubMed ID: 21992372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dosimetry system for boron neutron capture therapy based on the dual counter microdosimetric technique.
    Kota C; Maughan RL
    Bull Cancer Radiother; 1996; 83 Suppl():173s-5s. PubMed ID: 8949773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo simulation of 252CF dose distribution brachytherapy.
    Böhm R; Nikodemová D; Fülöp M; Pinak M
    Med Phys; 1996 May; 23(5):707-12. PubMed ID: 8724744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.